ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

Panel Unenthused About New Toxicity Testing Program

December 15, 1978

NCI, NSABP Launch Taxifin Trial For Prevention Of Breast Cancer

May 8, 1992

Children’s Memorial Hospital Receives $3 Million Endowment From Price Trust

May 28, 2010

Newell, Fredrickson Question Ethics Of Laetrile Trials

July 22, 1977

NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues

February 12, 1993

DCAB Board Okays One Contract Concept, Sends Another Back to Drawing Board

May 22, 1981